Search

everythinglearnresearchcommunity

for

Search:↓

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Five FDA-approved drugs may help block COVID-19 virus entry.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Researchers made new compounds that could potentially be developed into anticancer drugs.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

The method could improve vitiligo treatment by effectively delivering therapy to hair follicles.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

The gel is safe and effective for treating oral mucositis from chemotherapy and radiation.

Intranasal delivery of gene therapy shows promise for treating ischemic stroke.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

Soymetide-4 from soy can prevent hair loss caused by a cancer drug in rats.

AQB reduces harmful skin changes in systemic sclerosis.

Certain medications can cause serious side effects, so it's important to report them.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Adalimumab improved folliculitis decalvans in most patients.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.